Literature DB >> 22553930

Extraordinarily favorable left ventricular reverse remodeling through long-term cardiac resynchronization: super-response to cardiac resynchronization.

Özlem Çelebi1, Thomas Knaus, Florian Blaschke, Dirk Habedank, Wolfram Döhner, Aischa Nitardy, Martin Stockburger.   

Abstract

BACKGROUND: Some chronic heart failure (CHF) patients show remarkable improvement in left ventricular (LV) remodeling after cardiac resynchronization therapy (CRT), for unclear reasons. This study aimed at identifying predictors of an extraordinarily favorable response to CRT.
METHODS: We studied 136 CRT patients (104 men, median 66 years, QRS 162 ms, left ventricular ejection fraction 24 ± 7%, 70% coronary disease, all left bundle branch block [LBBB]). We measured LV end diastolic diameter (LVEDD) before and after long-term (9.4 ± 6.3 months) CRT. At baseline, LV pre-ejection interval (LVPEI), interventricular mechanical delay (IVMD), LV dyssynchrony (standard deviation of electromechanical delays [SDEMD] in eight LV segments), exercise capacity (pVO(2)), and ventilatory efficiency (VE/VCO(2)) were assessed. Patients with a LVEDD reduction beyond the 80th percentile (high responders [HR]) were compared to low responders (LR).
RESULTS: In the HR group (n = 22), LVEDD was reduced from 71 to 52 mm (LR 64-61 mm, P < 0.001). HR had predominantly nonischemic heart disease (HR: 72%, LR: 44%, P = 0.019), tended to have a wider QRS (HR: 178 ms, LR: 162 ms, P = 0.066), had a longer LVPEI (HR: 179 ms, LR: 155 ms, P = 0.004), wider IVMD (HR: 60 ms, LR 48 ms, P = 0.05), larger LVEDD (P = 0.002), higher SDEMD (HR: 69 ms, LR: 46 ms, P = 0.044), but higher pVO(2) (HR: 17.5 mL/min/kg, LR: 13.5 mL/kg/min, P = 0.025) and lower VE/VCO(2) (HR: 31, LR: 35, P = 0.043), all compared to LR patients.
CONCLUSION: Extraordinarily favorable reverse LV remodeling through CRT in CHF and LBBB appears to require a particularly dilated LV due to nonischemic heart disease with pronounced electromechanical alteration, but with a fairly preserved functional capacity before CRT. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22553930     DOI: 10.1111/j.1540-8159.2012.03417.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study.

Authors:  David Hürlimann; Susann Schmidt; Burkhardt Seifert; Ardan M Saguner; Gerhard Hindricks; Thomas F Lüscher; Frank Ruschitzka; Jan Steffel
Journal:  Clin Res Cardiol       Date:  2014-10-10       Impact factor: 5.460

Review 2.  The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis.

Authors:  Wenzhao Lu; Jinxuan Lin; Yan Dai; Keping Chen; Shu Zhang
Journal:  Heart Fail Rev       Date:  2021-02-27       Impact factor: 4.214

3.  Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy.

Authors:  Hye Bin Gwag; Kwang Jin Chun; Jin Kyung Hwang; Kyoung Min Park; Young Keun On; June Soo Kim; Seung Jung Park
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

4.  Novel blood pressure and pulse pressure estimation based on pulse transit time and stroke volume approximation.

Authors:  Joonnyong Lee; JangJay Sohn; Jonghyun Park; SeungMan Yang; Saram Lee; Hee Chan Kim
Journal:  Biomed Eng Online       Date:  2018-06-18       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.